LIUZHOU CITY, China, July 27 China BCTPharmacy Group, Inc., (OTC Bulletin Board: CNBI), ("China BCT" or the"Company"), a leading pharmaceutical distributor, retail pharmacy, andmanufacturer of pharmaceutical products in Guangxi Province, China, todayannounced that the Financial Industry Regulatory Authority (FINRA) confirmedthe Company's new corporate name, China BCT Pharmacy Group, Inc., effectiveJuly 22, 2010.
China BCT's former name was China Baicaotang Medicine Limited. There areno other changes to the Company's corporate structure, management team orbusiness operations. China BCT will continue to be quoted on the Over theCounter Bulletin Board under the ticker symbol "CNBI."
"We believe that our new corporate name more clearly reflects our corebusiness which integrates pharmaceutical distribution, pharmacy retailing, andpharmaceutical manufacturing. It is also simpler for customers and investorsto recognize," commented Mr. Hui Tian Tang, Chairman and Chief ExecutiveOfficer of China BCT.
About China BCT
China BCT is engaged in pharmaceutical distribution, pharmacy retailing,and the manufacture of pharmaceuticals products through its subsidiariesGuangxi Liuzhou Baicaotang Medicine Limited, Hefeng Pharmaceutical Co. Limited,and Guangxi Liuzhou Baicaotang Medicine Retail Limited in Guangxi province,China. It operates a large regional retail network in Guangxi province,consisting of 125 directly owned retail stores in Guangxi province andcurrently over 8,000 products are distributed through the Company's wholesaledistribution network. For more information, please visithttp://www.china-bct.com
Safe Harbor Statement
This press release contains "forward-looking statements" within themeaning of the safe-harbor provisions of the Private Securities LitigationReform Act of 1995. Such statements involve known and unknown risks,uncertainties and other factors that could cause the actual results of theCompany to differ materially from the results expressed or implied by suchstatements. The Company's actual results could differ materially from thoseanticipated in these forward-looking statements as a result of a variety offactors, including those discussed in the Company's periodic reports that arefiled with the Securities and Exchange Commission and available on its website(http://www.sec.gov ). Accordingly, although the Company believes that theexpectations reflected in such forward-looking statements are reasonable,there can be no assurance that such expectations will prove to be correct. TheCompany has no obligation to update the forward-looking information containedin this presentation.For more information, please contact: Company Contact: Ms. Shelly Zhang, Chief Financial Officer China BCT Pharmacy Group, Inc. Email: [email protected]
Tel: +86-772-363-8318 Web: http://www.china-bct.com Investor Relations Contact: Mr. Crocker Coulson, President CCG Investor Relations Email: [email protected]
Tel: +1-646-213-1915 Ms. Elaine Ketchmere VP of Financial Writing Email: [email protected]
Tel: +1-310-954-1345 CCG Investor Relations Web: http://www.ccgirasia.com
SOURCE China BCT Pharmacy Group, Inc.